| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LWSA3
|
4.30 | 2.4B | — | 1.01 | — | -6.8% | 23.0% | 48 | 28 | 8.27 | +44.4% | 74 | 0.03 |
|
TOTS3
|
35.45 | 20.3B | 22.33 | 4.09 | 14.19 | 11.5% | 17.7% | 38 | 25 | 19.46 | -33.8% | 72 | 0.98 |
|
CASH3
|
5.64 | 587.5M | — | 1.30 | 23.22 | 13.0% | 23.6% | 33 | 30 | 3.17 | -28.0% | 86 | 0.00 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.